These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 7295487)

  • 21. Platelet function after the administration of chlorpromazine to human subjects.
    Warlow C; Ogston D; Douglas AS
    Haemostasis; 1976; 5(1):21-6. PubMed ID: 1269995
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Double-blind comparative clinical trial of pimozide and chlorpromazine in mania. A test of the dopamine hypothesis.
    Cookson J; Silverstone T; Wells B
    Acta Psychiatr Scand; 1981 Nov; 64(5):381-97. PubMed ID: 7051755
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clinical significance of plasma chlorpromazine levels. II. Plasma levels of the drug, some of its metabolites and prolactin in patients receiving long-term phenothiazine treatment.
    Kolakowska T; Wiles DH; Gelder MG; McNeilly AS
    Psychopharmacology (Berl); 1976 Aug; 49(1):101-7. PubMed ID: 8814
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Olanzapine compared with chlorpromazine in treatment-resistant schizophrenia.
    Conley RR; Tamminga CA; Bartko JJ; Richardson C; Peszke M; Lingle J; Hegerty J; Love R; Gounaris C; Zaremba S
    Am J Psychiatry; 1998 Jul; 155(7):914-20. PubMed ID: 9659857
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A 6-week, multicenter, double-blind, double-dummy, chlorpromazine-controlled non-inferiorityrandomized phase iiitrial to evaluate the efficacy and safety of quetiapine fumarate (SEROQUEL) extended-release (XR) in the treatment of patients with schizophrenia and acute episodes.
    Li H; Shen Y; Wang G; Shi J; Ma C; Xie S; Zhang H; Wang X; Li K; Xu X; Gu N
    Psychiatry Res; 2018 Jan; 259():117-124. PubMed ID: 29040947
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prediction of response to chlorpromazine treatment in schizophrenics.
    Sakurai Y; Nakahara T; Takahashi R
    Psychopharmacologia; 1975 Oct; 44(2):195-203. PubMed ID: 1105634
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clinical significance of plasma drug and prolactin levels during acute chlorpromazine treatment: a replication study.
    Kolakowska T; Orr M; Gelder M; Heggie M; Wiles D; Franklin M
    Br J Psychiatry; 1979 Oct; 135():352-9. PubMed ID: 519119
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Changes in blink rates of Nigerian schizophrenics treated with chlorpromazine.
    Adamson TA
    West Afr J Med; 1995; 14(4):194-7. PubMed ID: 8634222
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Dehalogenation and N-dealkylation of chlorpromazine as revealed by plasma concentrations of metabolites in a population of chronically medicated schizophrenics.
    Valoti M; Palmi M; Della Corte L; Nardini M; Corti P; Sgaragli GP
    Methods Find Exp Clin Pharmacol; 1992; 14(6):445-50. PubMed ID: 1469953
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Chlorpromazine inhibits mitochondrial apoptotic pathway via increasing expression of tissue factor.
    Wu J; Li A; Li Y; Li X; Zhang Q; Song W; Wang Y; Ogutu JO; Wang J; Li J; Tang R; Zhang F
    Int J Biochem Cell Biol; 2016 Jan; 70():82-91. PubMed ID: 26592196
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of sarpogrelate, a 5-HT(2A) antagonist, on platelet aggregation in patients with ischemic stroke: clinical-pharmacological dose-response study.
    Uchiyama S; Ozaki Y; Satoh K; Kondo K; Nishimaru K
    Cerebrovasc Dis; 2007; 24(2-3):264-70. PubMed ID: 17622759
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects of reserpine and chlorpromazine on 5-hydroxytryptamine uptake of platelets from migrainous and control subjects.
    Hilton BP
    J Neurol Neurosurg Psychiatry; 1974 Jun; 37(6):711-4. PubMed ID: 4844137
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pimozide versus chlorpromazine in chronic schizophrenia: a 52 week double-blind study of maintenance therapy.
    Wilson LG; Roberts RW; Gerber CJ; Johnson MH
    J Clin Psychiatry; 1982 Feb; 43(2):62-5. PubMed ID: 7035441
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Alpha-methyldopa-chlorpromazine combination in schizophrenic patients.
    Chouinard G; Annable L
    Neuropsychobiology; 1976; 2(2-3):118-26. PubMed ID: 796755
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The risks and benefits of clozapine versus chlorpromazine.
    Claghorn J; Honigfeld G; Abuzzahab FS; Wang R; Steinbook R; Tuason V; Klerman G
    J Clin Psychopharmacol; 1987 Dec; 7(6):377-84. PubMed ID: 3323261
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Double-blind comparison of clozapine with chlorpromazine in acute schizophrenic illness.
    Chiu E; Burrows G; Stevenson J
    Aust N Z J Psychiatry; 1976 Dec; 10(4):343-7. PubMed ID: 798582
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clotiapine compared with chlorpromazine in chronic schizophrenia.
    Geller V; Gorzaltsan I; Shleifer T; Belmaker RH; Bersudsky Y
    Schizophr Res; 2005 Dec; 80(2-3):343-7. PubMed ID: 16126373
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Inhibition of 5-hydroxytryptamine-potentiated aggregation of human blood platelets by 5-hydroxytryptamine receptor-blocking agents.
    Glusa E; Markwardt F
    Biomed Biochim Acta; 1984; 43(2):215-20. PubMed ID: 6732757
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Platelet monoamine oxidase activity in schizophrenic patients.
    Becker RE; Shaskan EG
    Am J Psychiatry; 1977 May; 134(5):512-7. PubMed ID: 848577
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Predicting outcome of antipsychotic drug treatment from early response.
    May PR; Van Putten T; Yale C
    Am J Psychiatry; 1980 Sep; 137(9):1088-9. PubMed ID: 7425161
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.